NEW DATA – PREVENT Meets Primary Endpoint, a Detailed Look at the Final 3‑Year Results and Expert Discussion

Featured Faculty:
Dr. Chirag Shah, Co-Director Comprehensive Breast Program, Director of Breast Cancer Radiation Oncology and Director of Clinical Research, Department of Radiation Oncology, Cleveland Clinic
Dr. Pat Whitworth, Breast Surgeon, Nashville Breast Center
Maureen McBeth, MPT, CLT-LANA, Key Accounts Specialist, ImpediMed

VIEW WEBINAR

BREAKING NEWS! The results are in. And they’re conclusive.

PREVENT, the largest randomized clinical trial to assess lymphedema prevention met its primary endpoint and reached statistical significance. Join our expert panel Dr. Chirag Shah, Dr. Pat Whitworth, and Maureen McBeth as they dissect the trial results and discuss the implications of this new data to the future of cancer patient care. Bring your questions as there will be plenty of opportunity for Q&A.

Learning Objectives:

  • Understand the findings of PREVENT, the largest randomized controlled trial to study prevention of cancer-related lymphedema
  • Review case studies for using SOZO with L-Dex to assess subclinical lymphedema and associated treatment
  • Uncover best practices for implementing a program for early detection of lymphedema including workflows and reimbursement

VIEW WEBINAR

Featured Faculty

Dr. Chirag Shah,
Co-Director Comprehensive Breast Program, Director of Breast Cancer Radiation Oncology and Director of Clinical Research, Department of Radiation Oncology, Cleveland Clinic

Dr. Chirag Shah

Dr. Shah received his bachelor’s degree from Youngstown State University and his Medical degree from Northeast Ohio Medical University. He completed his internship, and residency at William Beaumont Hospital from 2007 to 2012 and joined the Cleveland Clinic Staff in 2015 where he is an associate professor in the department of radiation oncology.

Dr. Shah serves as a reviewer for various medical journals and is a member of various medical societies. His primary research interests are breast cancer, sarcoma, and innovative radiation treatment schedules as well as lymphedema. He has participated in numerous in-house, pharmaceutical and cooperative group trials.

Dr. Pat Whitworth
Breast Surgeon, Nashville Breast Center

Dr. Pat Whithworth

Pat Whitworth, MD has served as vice chair for breast research for the American College of Surgeons Oncology Group and chairman of the board for the American Society of Breast Surgeons.

Maureen McBeth, MPT, CLT-LANA, Key Accounts Specialist, ImpediMed

Maureen McBeth

Maureen has over 25 years’ experience as a physical therapist, specializing in lymphedema and cancer rehabilitation. She is a member of APTA and the Lymphatic Disorders Special Interest Group of the Academy of Oncologic Physical Therapy. She regularly speaks at conferences and continuing education programs, has been involved in a long-term volunteer project to help advance lymphedema care in Cali, Colombia, and supports the many lymphatic advocacy efforts in the US. Her passion is geared toward creating the knowledge base and driving the social connections to increase the adoption of new technology and clinical practice guidelines for prospective surveillance of cancer-related lymphedema.

ImpediMed SOZO Device featuring L-Dex Analysis

Learn More About SOZO®

SOZO uses ImpediMed’s BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. SOZO is non-invasive, fast, and easy to use. Results from the 30-second test* are available immediately providing proactive patient care including early detection of disease progression, treatment monitoring, and patient education.

*As tested on Android

Contact Us